Lifestyle Changes Ease AFib Symptoms but Don't Lower Burden vs Standard Care
Slow, Steady Advances: Noninvasive Diagnosis of PH in ILD Populations
Zenocutuzumab Approved for NRG1+ NSCLC and Pancreatic Adenocarcinoma
Tirzepatide Outperforms Semaglutide in Weight Loss Trial
Initiating PrEP Through the Emergency Department Has Pros, Cons to Improving Uptake
Proposal for Medicaid, Medicare Coverage of Obesity Drugs Could Prove Difficult
ICYMI: Highlights From EHA 2024
Who Lives to 100? New Research Reveals Differences Across Racial, Ethnic Groups
Policy Proposals Aim to Stimulate the Long-Term Sustainability of Infused Biosimilars
Optimizing Outcomes in NSCLC With Precision Medicine and Teamwork
Prior Authorization Delays Cause Serious Harm to Patients With Cancer
ICYMI: Highlights From ACCC Spring 2024
What You Need to Know About Seasonal Affective Disorder
Most Patients With Moderate to Severe Psoriasis Continue Secukinumab Treatment
Despite Medicare, US Seniors Struggle to Afford Care Compared With International Peers
Study Examines the Role of Race in Disease Risk Models
How Medical Journals Are Grappling With AI in Peer Review
Gene Therapy Enhances Visual Processing for Inherited Retinal Disease
Pregnancy Could Worsen Progression of Retinitis Pigmentosa
The Silver Lining: Progress and Promise in Combating STIs
Laryngeal MG Is Best Diagnosed With a Tensilon Test or Pyridostigmine Bromide Trial
Global Burden of Sickle Cell Disease Warrants Universal Access to Hydroxyurea, Experts Say
ICYMI: Highlights From Asembia 2024
Cancer Drug Prices Rise in the US Post Launch, Fall in Germany, Switzerland
CMS, HHS Finalize Mandatory Model to Boost Kidney Transplant Access, Equity
New Guidelines Clarify EORTC Quality of Life Scores for Chronic Lymphocytic Leukemia
CRC Incidence Risk Associated With Changes in Cardiorespiratory Fitness
Baseline Response Rates Inform Immunotherapy Sequencing in NSCLC
FDA Approves Sixth Ustekinumab Biosimilar, Yesintek
Balancing Cutting-Edge Therapies With Cost in Multiple Myeloma Treatment